← Eichor
Study identifier: NCT06880640 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Affect-based Impulsivity in Borderline Personality Disorder

Condition: Borderline Personality Disorder (BPD) · Healthy Controls Group - Age and Sex-matched  ·  Sponsor: University of North Carolina, Chapel Hill

PhaseNA
Planned participants106
Who can joinAll sexes, 18 Years to 45 Years
Healthy volunteersYes

About this study

The purpose of this research study is to investigate how personality traits and neuroendocrine systems relate to decision-making patterns in individuals 18-45 years old. The main question it aims to answer is how neuroendocrine activity impacts decision-making. Participants will complete online behavioral tasks, a stress induction procedure, self-report surveys, and a cognitive assessment. During the session, psychophysiological measures will be collected, including electrocardiogram (ECG) and cardiac impedance (ICG) to monitor heart rate and blood flow, as well as electrodermal activity (EDA), blood drop samples, and saliva collection to assess nervous system activity.

This description comes directly from the study's public registry record.

Talk to the study team

Keely A Muscatell, PhD  ·  +1 (919) 843-9113  ·  kmuscatell@unc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of North Carolina at Chapel HillChapel Hill, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06880640